AlphaGrid creates AI-powered digital twins of patient cancer journeys by integrating multimodal data into a unified, real-time insights platform. This engine transforms static imaging and genomic data into predictive tumor models, enabling oncologists to support early intervention and tailor care pathways.
Funding
Funding not disclosed
Founders
Product
Problem
Current oncology workflows are characterized by slow, disconnected diagnostic processes that lack visibility into tumor progression and real-time alerts. This fragmentation leads to missed tumor abnormalities, delayed follow-up scans, and a lack of standardization in reporting, hindering timely and precise cancer care.
Solution
AlphaGrid develops digital twins of patient cancer journeys by integrating multimodal data into a unified, real-time insights platform. This engine transforms static imaging and genomic data into predictive tumor models, enabling oncologists to support early intervention and tailor care pathways. By decoding imaging, histopathology, genomics, and lab reports within a patient-specific context and longitudinal history, AlphaGrid bridges fragmented diagnostics to facilitate precision oncology. The platform's AI-driven approach allows these digital replicas to evolve with new data, providing oncologists with dynamic insights into tumor progression and treatment response.
Target Audience
AlphaGrid targets oncologists and clinical researchers who require integrated, real-time data analysis for precision cancer care and early intervention strategies.
Features
- Integration of multimodal data including MRI, CT, PET, X-ray, histopathology, genomics, and lab reports into a single data pipeline.
- AI-powered digital twin engine that creates evolving, patient-specific replicas of cancer progression.
- Predictive modeling capabilities to forecast tumor behavior and treatment response.
- Longitudinal tracking of tumor changes and patient response to therapy.
- Decoding of raw data into structured digital twins with patient-specific context.
- Support for early intervention through real-time insights and predictive analytics.
- Facilitation of tailored care pathways based on dynamic tumor models.